Entity
  • Aureus Pharma

    Created in 2001
  • Social networks

    46 636
  • Activities

  • Technologies

  • Entity types

  • Location

    174 Quai de Jemmapes, 75010 Paris, France

    Paris

    France

  • Employees

    Scale: 11-50

    Estimated: 1

  • SIREN

    889034187
  • Engaged corporates

    0
    0 0
  • Added in Motherbase

    3 years, 6 months ago
Description
  • Value proposition

    Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases.

    Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes therapeutic target knowledgebases, ADME based databases and software applications:

    * AurSCOPE Kinase, GPCR, Ion Channel, Proteases and Nuclear Receptors
    * AurSCOPE ADME
    * AurQUEST, DDI Predict, AurPROFILER

    Aureus's customers include large as well as mid-size pharmaceutical and biotech groups in Europe and North America.

    The company is headquartered in Paris (France) and employs approximately 25 people, most of which are highly trained scientists in biology, pharmacology and medicinal chemistry.

    compound profiling, SAR selectivity, ADME, drug-drug interactions, therapeutic targets, off target, side effect, Kinase, GPCR, Ion Channels, Protease, Nuclear Receptors, AurQUEST, AurPROFILER, DDI Predict, and AurPASS

  • Original language

    Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases.

    Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes therapeutic target knowledgebases, ADME based databases and software applications:

    * AurSCOPE Kinase, GPCR, Ion Channel, Proteases and Nuclear Receptors
    * AurSCOPE ADME
    * AurQUEST, DDI Predict, AurPROFILER

    Aureus's customers include large as well as mid-size pharmaceutical and biotech groups in Europe and North America.

    The company is headquartered in Paris (France) and employs approximately 25 people, most of which are highly trained scientists in biology, pharmacology and medicinal chemistry.

Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Loading...
Loading...
Social network dynamics